The group’s principle activity is to provide preclinical neurobiology and CNS drug discovery solutions including helping pharmaceutical companies and not-for-profit organizations to validate targets and select compounds to advance in clinical trials. Specific customers of the group include 7TM Pharma, Adolor, and Astra Zeneca. The group operates from United States.
